Aljian Capital Management’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.3M Sell
8,896
-269
-3% -$48.8K 0.24% 58
2026
Q1
$1.35M Buy
9,165
+1,343
+17% +$218K 0.28% 52
2025
Q4
$1.52M Buy
7,822
+623
+9% +$148K 0.3% 44
2025
Q3
$2.02M Buy
7,199
+1,494
+26% +$380K 0.41% 36
2025
Q2
$1.25M Buy
5,705
+426
+8% +$68.8K 0.27% 51
2025
Q1
$738K Buy
5,279
+3,813
+260% +$621K 0.18% 67
2024
Q4
$244K Buy
1,466
+1
+0.1% +$178 0.05% 107
2024
Q3
$250K Buy
+1,465
New +$212K 0.06% 107

Other funds holding ORCL

Aljian Capital Management's ORCL Position: Q2 2026 in Review

Aljian Capital Management reduced its Oracle (ORCL) stake by 2.9% in Q2 2026, selling an estimated $48.8K and leaving 8,896 shares worth $1.3M. The position accounts for 0.24% of the portfolio, ranked #58.

Aljian Capital Management first reported a position in ORCL in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.02M in Q3 2025. 3,524 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Aljian Capital Management held 8,896 shares of Oracle worth $1.3M as of Q2 2026.
  • Aljian Capital Management sold 269 Oracle shares in Q2 2026, an estimated $48.8K.
  • Oracle made up 0.24% of Aljian Capital Management's portfolio in Q2 2026, its #58 holding.
  • Aljian Capital Management first reported a position in Oracle in Q3 2024 and has held it in 8 quarters since.
  • Aljian Capital Management's Oracle position peaked at $2.02M in Q3 2025.
  • 3,524 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Aljian Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.